Drug intelligence / Profile preview

Xiao'er Tui Re Granules

Development stage: Unknown
Lead developer: PegBio
Modality: Small Molecules
Administration: Oral

Overview

Xiao'er Tui Re Granules is a traditional Chinese medicine (TCM) herbal oral formulation developed and marketed by Shandong Wohua Pharmaceutical. It is specifically indicated for the treatment of pediatric fever, particularly for symptomatic fever reduction in children suffering from wind-heat colds. As a multi-herb TCM product, it functions through the synergistic effects of its herbal components to clear heat and detoxify, according to traditional principles, rather than targeting a single biological molecule in the Western pharmaceutical sense. The drug is administered orally in a granule form and is currently approved and marketed in China.

Brand names: Xiao'er Tui Re Granules
Other names: Xiaoer Tuire Granules小儿退热颗粒

Beyond the preview

Go deeper on Xiao'er Tui Re Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiao'er Tui Re Granules.

Explore the full profile